Exemestane breast cancer drug molecule

Exemestane breast cancer drug molecule


Rights Managed


Exemestane breast cancer drug, molecular model. This drug, marketed as Aromasin, is taken orally as a treatment for breast cancer. It inhibits the production of oestrogen, a hormone that stimulates the growth of breast cancer tumours, by inhibiting the aromastase enzyme that produces oestrogen from androgen steroid hormones. As a result the drug limits the growth of tumours. It also seems effective in reducing excessive oestrogen levels in men. In this model, atoms are represented by coloured spheres; carbon is green, hydrogen is white, and oxygen is red.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}